However, the clinical studies on angiotensin-converting enzyme (ACE) inhibitors in PAH demonstrated controversial results and therefore, no consensus opinion on the use of ACE inhibitors in patients with PAH exists [11]. Here, ACE is linked to pulmonary arterial hypertension.